Welcome to our dedicated page for SenesTech news (Ticker: SNES), a resource for investors and traders seeking the latest updates and insights on SenesTech stock.
SenesTech, Inc. (Nasdaq: SNES) is a pioneering biotechnology company based in the United States, specializing in the development of innovative fertility control solutions for managing animal pest populations. SenesTech is dedicated to improving global health through humane pest control methods, reducing the reliance on traditional lethal techniques.
The company’s flagship product, ContraPest®, is the first and only U.S. EPA-registered contraceptive for male and female rats. As a highly palatable liquid, ContraPest disrupts the reproductive cycle of Norway and roof rats, effectively reducing their populations. The product is dispensed inside tamper-resistant bait stations to minimize risks to non-target species and ensure the safety of handlers. ContraPest can be integrated into existing pest management programs or used as a standalone solution.
SenesTech's latest innovation, Evolve™, an EPA-designated minimum-risk contraceptive for rats, showcases the company's commitment to sustainable and humane pest control solutions. Evolve, available in a soft bait format, was launched in early 2024 and has already seen significant market acceptance. Its rapid adoption by distributors and end customers underscores its effectiveness in managing rodent populations by targeting their reproductive capabilities.
The company has expanded its reach by establishing distribution agreements with international partners, such as Agro Technic in Singapore, Evicom in Australia and New Zealand, and Q-chem in The Netherlands. These partnerships are pivotal in introducing SenesTech's fertility control solutions to new markets and enhancing global pest management strategies.
In addition to its product innovations, SenesTech has been recognized for its commercial achievements. The company was recently accepted as a vendor for Ace Hardware, allowing over 4,500 stores to order directly from SenesTech. Furthermore, SenesTech has launched a dedicated online store on Amazon, providing consumers and professionals with easy access to Evolve.
Financially, SenesTech reported record quarterly revenues in early 2024, driven by the rapid adoption of Evolve. The company's strategic initiatives, including the development of a contraceptive product for mice and operational efficiencies, are expected to sustain this growth trajectory.
SenesTech's mission is clear: to promote clean cities, efficient businesses, and happy households by providing humane, effective, and sustainable pest control solutions. For more information, visit SenesTech and ContraPest Store.
SenesTech, Inc. (SNES) announced that its innovative Elevate Bait System with ContraPest, the only EPA registered birth control for rats, is now available for purchase nationwide, including California. This system targets roof rats effectively, especially in agricultural settings. Since its initial launch, the system has gained rapid traction, and CEO Ken Siegel highlighted significant customer interest following approval from the California Department of Pesticide Regulation. The product aims to reduce rat populations, which can reproduce exponentially, with the potential to eliminate infestations more efficiently.
SenesTech, Inc. (SNES) has launched the Elevate Bait System, an innovative EPA-registered birth control solution for roof rats, now available for purchase in the U.S. The system is designed for deployment in elevated indoor spaces to effectively target and control rat populations. This follows successful trials, showing a 95% reduction in rat activity on poultry farms after using ContraPest. The system allows easy maintenance and has received EPA approval, except in California. This breakthrough aims to combat the rising roof rat populations causing significant property damage and health risks.
SenesTech (NASDAQ: SNES) reported a remarkable 122% increase in first-quarter 2022 sales, reaching approximately $195,000, compared to $88,000 the previous year. The launch of the Elevate Bait System™ with ContraPest is anticipated to enhance market penetration, particularly in agriculture, targeting above-ground rat infestations. Despite revenue growth, the company experienced a net loss of $(2.3) million, up from $(1.8) million in Q1 2021. Cash reserves stand at approximately $7.2 million. CEO Ken Siegel emphasized ongoing sales success and innovative market solutions.
SenesTech, Inc. (NASDAQ: SNES) will disclose its first quarter 2022 financial results on May 12, 2022, after market close. The company will hold a conference call at 5:00 pm ET the same day to discuss the results. SenesTech specializes in rodent fertility control through its product, ContraPest, aiming to reduce rat populations sustainably. For participation details, interested parties can dial (844) 308-3351 or access a live webcast on the company's investor relations website.
SenesTech, Inc. (NASDAQ: SNES) will participate in the Lytham Partners Spring 2022 Investor Conference from April 4-7, 2022. A webcast presentation will be available on April 4 at 11:00 AM ET on the company's website and can be archived for later viewing. Management will also hold virtual one-on-one meetings during the event. SenesTech specializes in rodent fertility control and offers ContraPest, the first U.S. EPA-registered contraceptive for rats, aiming to minimize pest populations sustainably.
SenesTech (NASDAQ: SNES) reported a significant increase in its 2021 revenue, reaching approximately $600,000, up 113% year-over-year. Product sales surged 123%, supported by expanded deployments of ContraPest® in various sectors, including government and wildlife preservation. The company's customer base grew by 300%. Despite a net loss of $(8.3) million, cash reserves stood at approximately $9.3 million. The recent EPA approval of the Elevate Bait System™ is expected to enhance market penetration further.
SenesTech, Inc. (NASDAQ: SNES) is set to release its financial results for the fourth quarter and fiscal year 2021, concluding on December 31, 2021, after market close on March 29, 2022. A conference call will follow at 5:00 PM ET on the same day, allowing stakeholders to review the results. The company specializes in rodent fertility control, offering ContraPest, the only EPA-registered contraceptive targeting male and female rats. This innovative solution aims to significantly reduce rat populations sustainably.
SenesTech, Inc. (SNES) has announced the EPA approval and launch of its Elevate Bait System with ContraPest, targeting rat infestations in above-ground locations. This innovative bait system allows for easy deployment in settings such as barns and granaries, significantly reducing servicing time with its design for quick bottle replacement. With ContraPest's proven ability to reduce rat populations by 60-90%, the company expects enhanced sales, particularly in agriculture, as state registrations progress for a mid-April shipping date.
SenesTech, Inc. (NASDAQ: SNES) has announced the deployment of its ContraPest® product at a 2,500-bed medium security correctional facility, marking a significant first for pest control in major correctional settings.
ContraPest, a non-lethal rodent birth control solution, is designed to tackle complex challenges in correctional environments, achieving population reduction in rats by at least 94%. The product is capable of being deployed in various locations and seeks to expand within institutional settings. CEO Ken Siegel noted the importance of this advancement for pest management professionals.
SenesTech, Inc. (NASDAQ: SNES) announced the deployment of its rodent fertility control product, ContraPest®, at Safari West Wildlife Preserve in California. This initiative is part of a broader eco-friendly pest management strategy, crucial for controlling rat populations that can rapidly reproduce in safe environments. ContraPest offers a non-lethal solution that has proven to reduce rat populations by at least 94%. The product is now increasingly being adopted in zoos and sanctuaries across the U.S., with expectations of continued growth in this market.
FAQ
What is the current stock price of SenesTech (SNES)?
What is the market cap of SenesTech (SNES)?
What is SenesTech, Inc.?
What products does SenesTech offer?
How does ContraPest work?
What are the benefits of using Evolve?
Who are SenesTech’s distribution partners?
Where can I purchase SenesTech products?
What is the financial outlook for SenesTech?
What makes SenesTech's products unique?
Are SenesTech’s products safe for non-target species?
What is SenesTech's mission?
